9T Labs expands team and moves its CFRTP 3D printing technology into new markets

9T Labs AG (Zurich, Switzerland) reports that in response to growing interest in its hybrid system for printing and molding structural carbon fiber-reinforced thermoplastic composites (CFRTP), the company has hired additional staff and is selling systems into new markets.

As 2022 begins, the company says it seeks to fill more open positions and anticipates strong sales and market expansion for its hybrid polymer additive manufacturing system.

Last year, the company reports a record number of new collaboration projects in the fields of aerospace (interior components, brackets, and engine components), advanced aerial mobility (rib stiffeners for wings), medical (surgical instruments), luxury (watchmaking, eyewear) and human exoskeletons (ergonomic support for lifting heavy loads). In addition to all the industrial projects, 9T Labs also delivered commercial systems to customers in research centers, universities, the metal-forming industry and aerospace Tier 1 suppliers.

To support the additional business, the company hired 21 new employees, including a number of new sales territory managers to cover all European countries.

Giovanni Cavolina, 9T Labs co-founder adn chief commercial officer, says, “Despite the challenges that all of industry has faced during the past two years, we are entering 2022 full of optimism. We have new systems out in the field being used to produce both developmental and commercial parts. And now, with many new production applications initiated last year, we have an additional pool of customers who will scale to series production using multiple 9T Red Series systems just as soon as the technology is validated for their particular target application.”

To support the additional growth anticipated for 2022, the company already plans to substantially increase its headcount and to open its first office center in the U.S. Additionally, 9T Labs expects that the first series production of advanced composites parts produced using its patented Additive Fusion Technology will become commercially available before end of the year.

Furthermore, the company is also working on developing further the technology to cover applications with a production volume beyond 100,000 per annum.

Cavolina continues, “Two regulated markets — aerospace and medical — will continue to be very important to us since they offer the highest scaling possibility. On top of that, with all the additional production application projects we’ve got underway, we are very excited to have acquired customers in the sporting goods, luxury goods, and general industrial segments as well. This helps us support manufacturers in a variety of industries to produce structural fiber-reinforced composite parts much faster, at lower cost, and still meet demanding performance and dimensional requirements.”

The company has also recently closed on its Series A investment round, and funds raised will help support this next phase of growth.

Read more about 9T Labs’ Red Series Additive Fusion Solution platform in “3D printed composites with 60% fiber, less than 1% voids.”